Charles Matine

Insider Reports History

Entity
Individual
Location
7 Rue Gustave, Flaubert, Paris, France
Signature
/s/ Charles Matine
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Charles Matine:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Bionik Laboratories Corp. Director Common Stock, par value $0.001 per share 207K $124K $0.60 Jun 9, 2023 Direct

Insider Reports Filed by Charles Matine

Symbol Company Period Transactions Value $ Form Type Date Filed Role
BNKL Bionik Laboratories Corp. Jun 9, 2023 1 $108K 4 Jun 21, 2023 Director